Nurse Practitioners can provide efficacious care to people with disabilities, resulting in cost savings, improved outcomes, and high value.
Researchers aimed to clarify the role of contextual effect in widely used nonpharmacologic, nonsurgical treatments for knee osteoarthritis by conducting a literature review of knee osteoarthritis trials.
Galcanezumab was found to significantly improve work productivity and reduce interictal burden in patients with treatment-resistant migraine, according to results from the phase 3 CONQUER study.
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
Prescription drug monitoring programs that aim to prevent opioid misuse may be affecting patients with cancer who need pain management.
Repetitive multiple cranial nerve blocks may offer a clinically meaningful benefit as a preventative measure in patients with chronic migraine.
The FDA has approved an expanded indication for the gammaCore device to include prevention of migraine.
Undergoing 20 sessions of manual acupuncture is superior to sham acupuncture and usual care for prophylactic treatment in migraine.
Depression is twice as common in patients with chronic pain compared to health subjects, and pain intensity, frequency, and number of locations are linked to depression and anxiety.
The guide includes information on a drug’s origin, common street names, how it is abused, what effect it has on the mind and body, what the overdose effects are, and what its legal status is in the US.
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
A single-center study showed that intranasal ketamine effectively reduced pain in children with migraine from hospital admission to discharge.
There is limited evidence supporting the prophylactic use of pharmacological therapies for the prevention of migraine in pediatric patients, according to the findings of a recently published systematic review and network meta-analysis.
Supportive conclusions seen in more studies with vs without CBD-related industry funding.
Each caplet contains 125mg of Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and 250mg of acetaminophen and is indicated for adults and children 12 years of age and older.
Among patients with obesity and migraine, weight loss is associated with reduction of migraine frequency, pain severity, and attack duration and disability.
Movement-based mind-body interventions could be effective alternatives to drugs, surgery, injections.
Kratom most commonly used daily; few serious adverse events self-reported among users.
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.